Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNA replication

Antiviral Research - Tập 99 - Trang 165-171 - 2013
Koen W.R. van Cleef1, Gijs J. Overheul1, Michael C. Thomassen1, Suzanne J.F. Kaptein2, Andrew D. Davidson3, Michael Jacobs4, Johan Neyts2, Frank J.M. van Kuppeveld1, Ronald P. van Rij1
1Department of Medical Microbiology, Radboud University Nijmegen Medical Centre, Nijmegen Centre for Molecular Life Sciences, Nijmegen Institute for Infection, Inflammation and Immunity, Nijmegen, The Netherlands
2Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, University of Leuven, Leuven, Belgium
3School of Cellular and Molecular Medicine, Faculty of Medical Sciences, University of Bristol, Bristol, United Kingdom
4Department of Infectious Diseases, Royal Free London Foundation Trust, London, United Kingdom

Tài liệu tham khảo

Alvarez, 2005, Role of RNA structures present at the 3′UTR of dengue virus on translation, RNA synthesis, and viral replication, Virology, 339, 200, 10.1016/j.virol.2005.06.009

Belov, 2007, Hijacking components of the cellular secretory pathway for replication of poliovirus RNA, J. Virol., 81, 558, 10.1128/JVI.01820-06

Botting, 2012, Novel approaches to flavivirus drug discovery, Expert Opin. Drug Discov., 7, 417, 10.1517/17460441.2012.673579

Desmyter, 1968, Defectiveness of interferon production and of rubella virus interference in a line of African green monkey kidney cells (Vero), J. Virol., 2, 955, 10.1128/JVI.2.10.955-961.1968

Diaz, 1988, Homozygous deletion of the a- and b1-interferon genes in human leukemia and derived cell lines, Proc. Natl. Acad. Sci. USA, 85, 5259, 10.1073/pnas.85.14.5259

Emeny, 1979, Regulation of the interferon system: evidence that Vero cells have a genetic defect in interferon production, J. Gen. Virol., 43, 247, 10.1099/0022-1317-43-1-247

Franco, 2010, The dengue threat to the United States, Biosecur. Bioterror., 8, 273, 10.1089/bsp.2010.0032

Gjenero-Margan, 2011, Autochthonous dengue fever in Croatia, August–September 2010, Euro Surveill., 16, 19805, 10.2807/ese.16.09.19805-en

Gualano, 1998, Identification of a major determinant of mouse neurovirulence of dengue virus type 2 using stably cloned genomic-length cDNA, J. Gen. Virol., 79, 437, 10.1099/0022-1317-79-3-437

Guzman, 2010, Update on the global spread of dengue, Int. J. Antimicrob. Agents, 36S, S40, 10.1016/j.ijantimicag.2010.06.018

Guzman, 2010, Dengue: a continuing global threat, Nat. Rev. Microbiol., 8, S7, 10.1038/nrmicro2460

Habjan, 2008, T7 RNA polymerase-dependent and -independent systems for cDNA-based rescue of Rift Valley fever virus, J. Gen. Virol., 89, 2157, 10.1099/vir.0.2008/002097-0

Holden, 2006, Inhibition of dengue virus translation and RNA synthesis by a morpholino oligomer targeted to the top of the terminal 3′ stem-loop structure, Virology, 344, 439, 10.1016/j.virol.2005.08.034

Julander, 2011, Important advances in the field of anti-dengue virus research, Antivir. Chem. Chemother., 21, 105, 10.3851/IMP1690

Kaptein, 2010, A derivate of the antibiotic doxorubicin is a selective inhibitor of dengue and yellow fever virus replication in vitro, Antimicrob. Agents Chemother., 54, 5269, 10.1128/AAC.00686-10

La Ruche, 2010, First two autochthonous dengue virus infections in metropolitan France, September 2010, Euro Surveill., 15, 19676, 10.2807/ese.15.39.19676-en

Massé, 2010, Dengue virus replicons: production of an interserotypic chimera and cell lines from different species, and establishment of a cell-based fluorescent assay to screen inhibitors, validated by the evaluation of ribavirin’s activity, Antiviral Res., 86, 296, 10.1016/j.antiviral.2010.03.010

McLamore, 2001, Effect of N-alkyl and N-alkenyl substituents in noroxymorphindole, 17-substituted-6,7-dehydro-4,5a-epoxy-3,14-dihydroxy-6,7:2′,3′-indolomorphinans, on opioid receptor affinity, selectivity, and efficacy, J. Med. Chem., 44, 1471, 10.1021/jm000511w

Miller, 2006, Subcellular localization and membrane topology of the dengue virus type 2 non-structural protein 4B, J. Biol. Chem., 281, 8854, 10.1074/jbc.M512697200

Mosca, 1986, Transcriptional and posttranscriptional regulation of exogenous human beta interferon gene in simian cells defective in interferon synthesis, Mol. Cell. Biol., 6, 2279, 10.1128/MCB.6.6.2279

Muñoz-Jordán, 2005, Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses, J. Virol., 79, 8004, 10.1128/JVI.79.13.8004-8013.2005

Muñoz-Jordán, 2003, Inhibition of interferon signaling by dengue virus, Proc. Natl. Acad. Sci. USA, 100, 14333, 10.1073/pnas.2335168100

Noble, 2010, Strategies for development of dengue virus inhibitors, Antiviral Res., 85, 450, 10.1016/j.antiviral.2009.12.011

Patkar, 2009, Identification of inhibitors of yellow fever virus replication using a replicon-based high-throughput assay, Antimicrob. Agents Chemother., 53, 4103, 10.1128/AAC.00074-09

Pryor, 2001, Replication of dengue virus type 2 in human monocyte-derived macrophages: comparisons of isolates and recombinant viruses with substitutions at amino acid 390 in the envelope glycoprotein, Am. J. Trop. Med. Hyg., 65, 427, 10.4269/ajtmh.2001.65.427

Reed, 1938, A simple method of estimating fifty per cent endpoints, Am. J. Hyg., 27, 493

WHO, 2013. Global alert and response (GAR). Dengue/dengue haemorrhagic fever. Available from: http://www.who.int/csr/disease/dengue/en/index.html (accessed May 2013).

Xie, 2011, Inhibition of dengue virus by targeting viral NS4B protein, J. Virol., 85, 11183, 10.1128/JVI.05468-11

Thông tin
Thông tin xuất bản

Antiviral Research

Tập 99

165-171

Thông tin tác giả